4.7 Review

Protein arginine methyltransferases and cancer

Journal

NATURE REVIEWS CANCER
Volume 13, Issue 1, Pages 37-50

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3409

Keywords

-

Categories

Funding

  1. US National Institutes of Health [DK62248]
  2. CPRIT [RP110471]
  3. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062248, R56DK062248] Funding Source: NIH RePORTER

Ask authors/readers for more resources

There are nine protein arginine methyltransferases (PRMTs) encoded in mammalian genomes, the protein products of which catalyse three types of arginine methylation - monomethylation and two types of dimethylation. Protein arginine methylation is an abundant modification that has been implicated in signal transduction, gene transcription, DNA repair and mRNA splicing, among others. Studies have only recently linked this modification to carcinogenesis and metastasis. Sequencing studies have not generally found alterations to the PRMTs; however, overexpression of these enzymes is often associated with various cancers, which might make some of them viable targets for therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available